
Nov 4, 2026
Greener Biomanufacturing Starts Beyond the Bioreactor
A recent study highlights that the energy consumption in monoclonal antibody production is largely influenced by facility infrastructure rather than just bioreactor technology.Research indicates that around 85% of the energy demand in antibody manufacturing is attributed to the facility's infrastructure, including HVAC systems, lighting, and utilities. Specifically, HVAC systems alone account for nearly half of the total energy use, with lighting contributing significantly as well. This suggests






